Cargando…

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices

Triggering receptor expressed by myeloid cells 2 (TREM2), a member of the immunoglobulin superfamily, has anti‐inflammatory phagocytic function in myeloid cells. Several studies have shown that TREM 2 gene variant rs75932628‐T increased the risks for Alzheimer's disease (AD), Parkinson's d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lue, Lih‐Fen, Schmitz, Christopher T., Serrano, Geidy, Sue, Lucia I., Beach, Thomas G., Walker, Douglas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427527/ https://www.ncbi.nlm.nih.gov/pubmed/25186950 http://dx.doi.org/10.1111/bpa.12190

Ejemplares similares

Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology
por: Mendsaikhan, Anarmaa, et al.
Publicado: (2019)

Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains
por: Walker, Douglas G., et al.
Publicado: (2020)

Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research
por: Beh, Suet Theng, et al.
Publicado: (2020)

Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases
por: Walker, Douglas G., et al.
Publicado: (2016)

Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin
por: Walker, Douglas G., et al.
Publicado: (2019)

Alzheimer’s Disease Research Using Human Microglia
por: Lue, Lih-Fen, et al.
Publicado: (2019)

Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
por: Beach, Thomas G, et al.
Publicado: (2011)

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
por: Sabbagh, Marwan N, et al.
Publicado: (2013)

Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
por: Walker, Douglas G., et al.
Publicado: (2015)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

The role of sex differences in depression in pathologically defined Alzheimer’s disease
por: Tremblay, Cécilia, et al.
Publicado: (2023)

TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017)

Anti-inflammatory and Immune Therapy for Alzheimer's Disease: Current Status and Future Directions
por: Walker, Douglas, et al.
Publicado: (2007)

Inflammation and the pathological progression of Alzheimer’s disease are associated with low circulating choline levels
por: Judd, Jessica M., et al.
Publicado: (2023)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer’s Disease
por: Piras, Ignazio S., et al.
Publicado: (2023)

PT581. Multiple accumulation of neurodegenerative disease-related proteins in familial granulin mutation brains
por: Hosokawa, Masato, et al.
Publicado: (2016)

TREM2 in CNS homeostasis and neurodegenerative disease
por: Painter, Meghan M., et al.
Publicado: (2015)

Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia
por: Walker, Douglas G., et al.
Publicado: (2017)

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
por: Lue, Lih-Fen, et al.
Publicado: (2012)

Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease
por: McAleese, Kirsty E., et al.
Publicado: (2017)

TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015)

Association between Cerebrospinal Fluid Soluble TREM2, Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Zhou, Wenchuan, et al.
Publicado: (2023)

TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
por: Natale, Gianfranco, et al.
Publicado: (2019)

The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
por: Beach, Thomas G., et al.
Publicado: (2008)

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
por: Zhong, Li, et al.
Publicado: (2019)

Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation
por: Hosokawa, Masato, et al.
Publicado: (2017)

The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
por: Zhong, Li, et al.
Publicado: (2019)

Effect of olfactory bulb pathology on olfactory function in normal aging
por: Tremblay, Cécilia, et al.
Publicado: (2022)

New insights into the role of TREM2 in Alzheimer’s disease
por: Gratuze, Maud, et al.
Publicado: (2018)

Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease
por: Beach, Thomas G., et al.
Publicado: (2021)

Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
por: Maarouf, Chera L., et al.
Publicado: (2014)

Delayed primacy recall performance predicts post mortem Alzheimer’s disease pathology from unimpaired ante mortem cognitive baseline
por: Bruno, Davide, et al.
Publicado: (2023)

Author Correction: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
por: Zhong, Li, et al.
Publicado: (2019)

Proteomics of neurodegenerative diseases: analysis of human post‐mortem brain
por: Li, K. W., et al.
Publicado: (2018)

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome
por: Raha-Chowdhury, Ruma, et al.
Publicado: (2018)

Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
por: Wang, Shoutang, et al.
Publicado: (2020)

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology
por: Schmitz, Taylor W., et al.
Publicado: (2016)

Acute Brain Ischemia, Infarction and Hemorrhage in Subjects Dying with or Without Autopsy-Proven Acute Pneumonia
por: Beach, Thomas G., et al.
Publicado: (2021)

Secretory PLA(2)-IIA: a new inflammatory factor for Alzheimer's disease
por: Moses, Guna SD, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ab1mimtt0qoq8gickicbs7ute9